151 related articles for article (PubMed ID: 37007149)
1. Hypofractionated whole breast irradiation with simultaneous integrated boost in breast cancer using helical tomotherapy with or without regional nodal irradiation: A report of acute toxicities.
Chitapanarux I; Nobnop W; Onchan W; Klunklin P; Nanna T; Sitathanee C; Kulpisitthicharoen S; Sripan P
Front Oncol; 2023; 13():1122093. PubMed ID: 37007149
[TBL] [Abstract][Full Text] [Related]
2. Modern Rotational Radiation Techniques with Volumetric Modulated Arc Therapy or Helical Tomotherapy for Optimal Sparing of the Lung and Heart in Left-Breast Cancer Radiotherapy Plus Regional Nodal Irradiation: A Comparative Dosimetric Analysis.
Hou PY; Hsieh CH; Wu LJ; Hsu CX; Kuo DY; Lu YF; Tien HJ; Hsiao HW; Shueng PW; Hsu SM
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680189
[TBL] [Abstract][Full Text] [Related]
3. Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer.
Montero A; Ciérvide R; Cañadillas C; Álvarez B; García-Aranda M; Alonso R; López M; Chen-Zhao X; Alonso L; Valero J; Sánchez E; Hernando O; García de Acilu P; Fernandez-Letón P; Rubio C
Clin Transl Radiat Oncol; 2023 Jul; 41():100651. PubMed ID: 37388711
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated regional nodal irradiation for breast cancer: examining the data and potential for future studies.
Badiyan SN; Shah C; Arthur D; Khan AJ; Freedman G; Poppe MM; Vicini FA
Radiother Oncol; 2014 Jan; 110(1):39-44. PubMed ID: 24440047
[TBL] [Abstract][Full Text] [Related]
5. 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.
Gupta A; Khan AJ; Yegya-Raman N; Sayan M; Ahlawat S; Ohri N; Goyal S; Moore DF; Eladoumikdachi F; Toppmeyer D; Haffty BG
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):267-274. PubMed ID: 31175905
[TBL] [Abstract][Full Text] [Related]
6. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.
Moreno AC; Lin YH; Bedrosian I; Shen Y; Stauder MC; Smith BD; Buchholz TA; Babiera GV; Woodward WA; Shaitelman SF
Adv Radiat Oncol; 2017; 2(3):291-300. PubMed ID: 29114595
[TBL] [Abstract][Full Text] [Related]
7. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Heart and Lung Doses According to Tumor Bed Boost Techniques in Early-Stage Left-Sided Breast Cancer: Simultaneous Integrated Boost versus Sequential Boost.
Kim M; Lee NK; Lee S; Hwang J
Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888592
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary results of whole breast helical tomotherapy with simultaneous integrated boost in the adjuvant treatment of breast cancer].
Liem X; Chira C; Fourquet A; Campana F; Peurien D; Fournier-Bidoz N; Kirova YM
Cancer Radiother; 2014 Jan; 18(1):15-22. PubMed ID: 24316350
[TBL] [Abstract][Full Text] [Related]
10. Toxicity Evaluation of Dose-Escalation in Hypofractionated Regional Nodal Irradiation for Breast Cancer: A Retrospective Study.
Kim E; Yoo JS; Kim YJ; Joo J; Oh ES; Chung Y; Chung SH; Kim TH
Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38631540
[TBL] [Abstract][Full Text] [Related]
11. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients.
Karasawa K; Kunogi H; Hirai T; Hojo H; Hirowatari H; Izawa H; Ito K; Sasai K; Kawashima M; Furuya T; Sugimoto S; Kurokawa C; Ozawa S; Saito M
Breast Cancer; 2014 Jul; 21(4):402-8. PubMed ID: 22968629
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
15. Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial.
Paelinck L; Gulyban A; Lakosi F; Vercauteren T; De Gersem W; Speleers B; Monten C; Mulliez T; Berkovic P; van Greveling A; Decoster F; Coucke P; De Neve W; Veldeman L
Radiother Oncol; 2017 Jan; 122(1):30-36. PubMed ID: 28062087
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701).
Kim H; Kim H; Park W; Baek JY; Ahn SJ; Kim MY; Park SH; Lee IJ; Ha I; Kim JH; Kim TH; Lee KC; Lee HS; Kim TG; Kim JH; Lee JH; Jung J; Cho O; Chang JS; Kim ES; Jo IY; Koo T; Kim K; Park HJ; Shin YJ; Ha B; Kwon J; Lee JH; Moon S
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33158245
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated Helical Tomotherapy for Older Aged Patients With Prostate Cancer: Preliminary Results of a Phase I-II Trial.
Liu HX; Du L; Yu W; Cai BN; Xu SP; Xie CB; Ma L
Technol Cancer Res Treat; 2016 Aug; 15(4):546-54. PubMed ID: 26152749
[TBL] [Abstract][Full Text] [Related]
18. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
Scorsetti M; Alongi F; Fogliata A; Pentimalli S; Navarria P; Lobefalo F; Garcia-Etienne C; Clivio A; Cozzi L; Mancosu P; Nicolini G; Vanetti E; Eboli M; Rossetti C; Rubino A; Sagona A; Arcangeli S; Gatzemeier W; Masci G; Torrisi R; Testori A; Alloisio M; Santoro A; Tinterri C
Radiat Oncol; 2012 Aug; 7():145. PubMed ID: 22929062
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds.
Yadav BS; Dey T
Clin Breast Cancer; 2024 Mar; ():. PubMed ID: 38614852
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer.
Tramacere F; Arcangeli S; Colciago RR; Lucchini R; Pati F; Portaluri M
Br J Radiol; 2022 Jul; 95(1135):20211299. PubMed ID: 35522785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
